178 related articles for article (PubMed ID: 23845615)
1. Wilms tumor survival in Kenya.
Axt J; Abdallah F; Axt M; Githanga J; Hansen E; Lessan J; Li M; Musimbi J; Mwachiro M; Newton M; Ndung'u J; Njuguna F; Nzioka A; Oruko O; Patel K; Tenge R; Ukoli F; White R; O'Neill JA; Lovvorn HN
J Pediatr Surg; 2013 Jun; 48(6):1254-62. PubMed ID: 23845615
[TBL] [Abstract][Full Text] [Related]
2. The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group.
Hamilton TE; Ritchey ML; Haase GM; Argani P; Peterson SM; Anderson JR; Green DM; Shamberger RC
Ann Surg; 2011 May; 253(5):1004-10. PubMed ID: 21394016
[TBL] [Abstract][Full Text] [Related]
3. Bilateral Wilms tumors: Treatment results from a single center.
Aydın B; Akyüz C; Yalçın B; Ekinci S; Oğuz B; Akçören Z; Yıldız F; Varan A; Kurucu N; Büyükpamukçu M; Kutluk T
Turk J Pediatr; 2019; 61(1):44-51. PubMed ID: 31559721
[TBL] [Abstract][Full Text] [Related]
4. Management and outcome of pediatric metastatic Wilms' tumor at the National Cancer Institute, Egypt.
Elayadi M; Magdy S; Khalil E; Zekri W
J Egypt Natl Canc Inst; 2020 Apr; 32(1):19. PubMed ID: 32372204
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Wilms' tumor in eastern China: 10 years of experience at a single center.
Yao W; Li K; Xiao X; Gao J; Dong K; Xiao X; Lv Z
J Invest Surg; 2012 Jun; 25(3):181-5. PubMed ID: 22583015
[TBL] [Abstract][Full Text] [Related]
6. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
[TBL] [Abstract][Full Text] [Related]
7. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
[TBL] [Abstract][Full Text] [Related]
9. Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children's Oncology Group/National Wilms Tumor Study Group.
Ehrlich PF; Ferrer FA; Ritchey ML; Anderson JR; Green DM; Grundy PE; Dome JS; Kalapurakal JA; Perlman EJ; Shamberger RC
Ann Surg; 2009 Oct; 250(4):642-8. PubMed ID: 19730241
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 Registry.
Dávila Fajardo R; Oldenburger E; Rübe C; López-Yurda M; Pritchard-Jones K; Bergeron C; Graf N; van Grotel M; van Tinteren H; Saunders D; van den Heuvel-Eibrink MM; Janssens GO; Oldenburger F
Pediatr Blood Cancer; 2018 Aug; 65(8):e27085. PubMed ID: 29693799
[TBL] [Abstract][Full Text] [Related]
11. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS;
Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.
Hol JA; Lopez-Yurda MI; Van Tinteren H; Van Grotel M; Godzinski J; Vujanic G; Oldenburger F; De Camargo B; Ramírez-Villar GL; Bergeron C; Pritchard-Jones K; Graf N; Van den Heuvel-Eibrink MM
PLoS One; 2019; 14(8):e0221373. PubMed ID: 31425556
[TBL] [Abstract][Full Text] [Related]
13. Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital.
Dome JS; Liu T; Krasin M; Lott L; Shearer P; Daw NC; Billups CA; Wilimas JA
J Pediatr Hematol Oncol; 2002; 24(3):192-8. PubMed ID: 11990305
[TBL] [Abstract][Full Text] [Related]
14. Relapsed Wilms' tumor in pediatric patients: challenges in low- to middle-income countries-a single-center experience.
Zekri W; Yacoub DM; Ibrahim A; Madney Y
J Egypt Natl Canc Inst; 2020 May; 32(1):21. PubMed ID: 32372372
[TBL] [Abstract][Full Text] [Related]
15. Outcome of Wilms tumor patients with bone metastasis enrolled on National Wilms Tumor Studies 1-5: A report from the Children's Oncology Group.
Iaboni DSM; Chi YY; Kim Y; Dome JS; Fernandez CV
Pediatr Blood Cancer; 2019 Jan; 66(1):e27430. PubMed ID: 30160355
[TBL] [Abstract][Full Text] [Related]
16. Surgical aspects in the treatment of patients with unilateral wilms tumor: a report from the SIOP 93-01/German Society of Pediatric Oncology and Hematology.
Fuchs J; Kienecker K; Furtwängler R; Warmann SW; Bürger D; Thürhoff JW; Hager J; Graf N
Ann Surg; 2009 Apr; 249(4):666-71. PubMed ID: 19300220
[TBL] [Abstract][Full Text] [Related]
17. Extended followup of bilateral Wilms tumor: results of the National Wilms Tumor Study.
Montgomery BT; Kelalis PP; Blute ML; Bergstralh EJ; Beckwith JB; Norkool P; Green DM; D'Angio GJ
J Urol; 1991 Aug; 146(2 ( Pt 2)):514-8. PubMed ID: 1650403
[TBL] [Abstract][Full Text] [Related]
18. Wilms' tumor--lessons and outcomes--a 25-year single center UK experience.
Fawkner-Corbett DW; Howell L; Pizer BL; Dominici C; McDowell HP; Losty PD
Pediatr Hematol Oncol; 2014 Aug; 31(5):400-8. PubMed ID: 24933082
[TBL] [Abstract][Full Text] [Related]
19. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
Aronson DC; Hadley GP
Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
[TBL] [Abstract][Full Text] [Related]
20. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
